Home › Trial NCT05674240
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
- Trial IDNCT05674240
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorWake Forest University Health Sciences
- Enrollment30
- Start date2022-12-06
- ConditionsCancer Pain · Chronic Pain · Cancer Associated Pain · Neuropathic Pain
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.